Granite Point Capital Management’s bluebird bio BLUE Stock Holding History

Granite Point Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,160	Closed	-$9.6M	–	145
2021 Q2	$9.6M	Buy	23,160 +11,580	+100%	+$4.59M	0.36%	16
2021 Q1	$4.52M	Buy	+11,580	New	+$5.7M	0.17%	52

Other funds holding BLUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Granite Point Capital Management's BLUE Position: Q3 2021 in Review

Granite Point Capital Management sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 10,036 shares — an estimated $4.16M sold.

Granite Point Capital Management first reported a position in BLUE in Q3 2015 and held it in 3 quarters. The position peaked at $7.24M in Q1 2021. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

Granite Point Capital Management reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
Granite Point Capital Management sold 10,036 bluebird bio shares in Q3 2021, an estimated $4.16M.
Granite Point Capital Management first reported a position in bluebird bio in Q3 2015 and held it in 3 quarters.
Granite Point Capital Management's bluebird bio position peaked at $7.24M in Q1 2021.
196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Granite Point Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.